Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

October 20th, 2016

Cook Medical donates $1 Million to advance the Indiana Biosciences Research Institute

Indianapolis, Ind. – The Indiana Biosciences Research Institute (IBRI) today announced a $1 million research grant from Cook Medical to support the next phase of growth for the Institute dedicated to discovery science and applied research leading to innovation targeting cardio-metabolic disease, diabetes, and poor nutrition.  The donation will be matched through a grant from the Lilly Endowment.

“We are extremely pleased to have Cook Medical join the IBRI as a founding stakeholder,” said David Broecker, President and CEO of the IBRI. “What makes the IBRI unique is broad-based support from Indiana’s diverse set of leading life sciences and technology companies. Cook Medical is an innovative global company, and not just in medical devices. Cook is creating interesting capabilities and products in areas of regenerative medicine and cellular therapies and we are excited by the potential treatment options this could provide for patients. We look forward to working with Cook scientists and engineers in this area.”

Cook Medical joins other leading life science companies including Dow AgroSciences, Eli Lilly and Company, and Roche Diagnostics as Institute Founders and scientific advisory board members.  Other Institute Founders include the State of Indiana, Lilly Endowment, Indiana University Health, and the Indiana University School of Medicine.

“We’re proud to support the IBRI and their pursuit to attract the best and brightest to Indiana to develop and discover the next generation of medical breakthroughs,” said Steve Ferguson, chairman of the board of Cook Group. “The partnership with IBRI provides opportunities to improve patient care while stimulating Indiana’s economy through the life sciences industry.”

The IBRI is an independent research institute focused on attracting top entrepreneurial researchers who are pursuing on breakthrough science and innovation.  This so-called “Discovery With Purpose” is what motivates institute scientists to translate research in collaboration with a variety of others including philanthropic, academic and industry partners.

The institute was established in 2013 with initial funding of $25 million from the State of Indiana and an additional $25 million from the Lilly Endowment and other leading life sciences entities. The Lilly Endowment and the Lilly Foundation provided an additional $85 million in support and matching commitments in early 2016.

About Indiana Biosciences Research Institute
The Indiana Biosciences Research Institute (IBRI) is an independent, nonprofit discovery science and applied research institute focused on innovation targeting cardio-metabolic diseases, diabetes and poor nutrition. Inspired by the state and Indiana’s leading life sciences companies, research universities and philanthropic community, the IBRI is building a world-class organization of researchers, innovators, and entrepreneurs that will catalyze scientific discovery and its application, resulting in improved health outcomes for patients. For more information about IBRI and donation or collaboration opportunities, please visit

About Cook Medical
Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at, and for the latest news, follow us on TwitterFacebook and LinkedIn.